You are here » Home » Companies » Company Overview » Achyut Healthcare Ltd

Achyut Healthcare Ltd.

BSE: 543499 Sector: Others
NSE: N.A. ISIN Code: INE0K1401012
BSE 00:00 | 13 May 20.00 0
(0.00%)
OPEN

20.00

HIGH

20.00

LOW

20.00

NSE 05:30 | 01 Jan Achyut Healthcare Ltd
OPEN 20.00
PREVIOUS CLOSE 20.00
VOLUME 6000
52-Week high 21.50
52-Week low 19.90
P/E 2000.00
Mkt Cap.(Rs cr) 13
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 20.00
CLOSE 20.00
VOLUME 6000
52-Week high 21.50
52-Week low 19.90
P/E 2000.00
Mkt Cap.(Rs cr) 13
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Achyut Healthcare Ltd. (ACHYUTHEALTHCAR) - Auditors Report

Company auditors report

To

The Board of Directors Achyut HealthcareLimited

(Formerly known as Achyut Healthcare Private Limited)

610 Colonade B/H Iscon Temple Opp. Iscon BRTS Bus Stand Iscon-Ambali RoadAhmedabad - 380058

1. We have examined the attached restated financial information of Achyut HealthcareLimited (Formerly known as Achyut Healthcare Private Limited) (hereinafter referred to as"the Company") comprising the restated statement of assets and liabilitiesas at August 31 2021 and March 31 2021 2020 and 2019 restated statement of profit andloss and restated cash flow statement for the financial period/year ended on August 312021 March 31 2021 2020 and 2019 and the summary statement of significant accountingpolicies and other explanatory information (collectively referred to as the"restated financial information" or "restated financial statements")annexed to this report and initialed by us for identification purposes. These RestatedFinancial Statements have been prepared by the management of the Company and approved bythe board of directors at their meeting in connection with the proposed Initial PublicOffering on SME Platform ("IPO" or "SME IPO") of Bombay StockExchange of India Limited ("BSE") of the company.

2. These restated summary statements have been prepared in accordance with therequirements of:

(i) Section 26 of Part - I of Chapter III of Companies Act 2013 (the"Act") read with Companies (Prospectus and Allotment of Securities) Rules2014;

(ii) The Securities and Exchange Board of India (Issue of Capital and DisclosureRequirements) Regulations 2018 ("ICDR Regulations") and relatedamendments / clarifications from time to time issued by the Securities and ExchangeBoard of India ("SEBI");

(iii) The Guidance Note on Reports in Company Prospectuses (Revised 2019) issued by theInstitute of Chartered Accountants of India ("Guidance Note")

3. The Company's Board of Directors is responsible for the preparation of theRestated Financial

Statements for inclusion in the DRHP to be filed with Securities and Exchange Board ofIndia ("SEBI") BSE and Registrar of Companies (Gujarat) in connection with theproposed IPO. The Restated Financial Statements have been prepared by the management ofthe Company on the basis of preparation stated in Annexure IV to the Restated FinancialStatements. The responsibility of the board of directors of the Company includesdesigning implementing and maintaining adequate internal control relevant to thepreparation and presentation of the Restated Financial Statements. The board of directorsare also responsible for identifying and ensuring that the Company complies with the ActICDR Regulations and the Guidance Note.

4. We have examined such Restated Financial Statements taking into consideration:

(i) The terms of reference and terms of our engagement letter requesting us to carryout the assignment in connection with the proposed SME IPO;

(ii) The Guidance Note also requires that we comply with the ethical requirements ofthe Code of Ethics issued by the ICAI;

(iii) Concepts of test checks and materiality to obtain reasonable assurance based onverification of evidence supporting the Restated Financial Statements;

(iv) The requirements of Section 26 of the Act and the ICDR Regulations. Our work wasperformed solely to assist you in meeting your responsibilities in relation to yourcompliance with the Act the ICDR Regulations and the Guidance Note in connection with theIPO.

5. The Restated Financial Statements of the Company have been compiled by themanagement from audited financial statements for the period/year ended on August 31 2021and March 31 2021 2020 and 2019.

6. Audit for the financial period/year ended on August 31 2021 and March 31 20212020 and 2019was conducted by M/s. J K Parmar & Co. There are no audit qualificationsin the audit reports issued by us which would require adjustments in the RestatedFinancial Statements of the Company. The financial report included for these period/yearsis based solely on the report submitted by us. Further financial statements for thefinancial period/year ended on August 31 2021 and March 31 2021 have been re-audited byus as per the relevant guidelines.

7. Based on our examination and according to information and explanations given to uswe are of the opinion that the Restated Financial Statements:

a) have been prepared after incorporating adjustments for the changes in accountingpolicies material errors and regrouping / reclassifications retrospectively in thefinancial period/year ended on August 31 2021 and March 31 2021 2020 and 2019.

b) do not require any adjustment for modification as there is no modification in theunderlying audit reports.

c) there are no extra-ordinary items that need to be disclosed separately in theaccounts and requiring adjustments.

d) have been prepared in accordance with the Act ICDR Regulations and Guidance Note.

8. In accordance with the requirements of the Act including the rules made there underICDR Regulations Guidance Noteand engagement letter we report that:

(i) The "restated statement of asset and liabilities" of theCompany as at August 31 2021 and March 31 2021 2020 and 2019 examined by us as set outin Annexure I to this report read with significant accounting policies in AnnexureIV has been arrived at after making such adjustments and regroupings to the auditedfinancial statements of the Company as in our opinion were appropriate and more fullydescribed in notes to the restated summary statements to this report.

(ii) The "restated statement of profit and loss" of the Companyfor the financial period/year ended on at August 31 2021 and March 31 2021 2020 and2019 examined by us as set out in Annexure II to this report read with significantaccounting policies in Annexure IV has been arrived at after making suchadjustments and regroupings to the audited financial statements of the Company as in ouropinion were appropriate and more fully described in notes to the restated summarystatements to this report.

(iii) The "restated statement of cash flows" of the Company forthe financial period/year ended on at August 31 2021 and March 31 2021 2020 and 2019examined by us as set out in Annexure III to this report read with significantaccounting policies in Annexure IV has been arrived at after making suchadjustments and regroupings to the audited financial statements of the Company as in ouropinion were appropriate and more fully described in notes to restated summary statementsto this report.

9. We have also examined the following other financial information relating to theCompany prepared by the management and as approved by the board of directors of theCompany and annexed to this report relating to the Company for the financial period/yearended on at August 31 2021 and March 31 2021 2020 and 2019 proposed to be included inthe Draft Prospectus / Prospectus ("Offer Document").

Annexure to Restated Financial Statements of the Company:-

i) Summary statement of assets and liabilities as restated as appearing in ANNEXURE I;

ii) Summary statement of profit and loss as restated as appearing in ANNEXURE II;

iii) Summary statement of cash flows as restated as appearing in ANNEXURE III;

iv) Corporate Information Significant accounting policies as restated and Notes toreconciliation of restated profits and networth as appearing in ANNEXURE IV;

v) Details of share capital as restated as appearing in ANNEXURE V to this report;

vi) Details of reserves and surplus as restated as appearing in ANNEXURE VI to thisreport;

vii) Details of trade payables as restated as appearing in ANNEXURE VII to this report;

viii) Details of other current liabilities as restated as appearing in ANNEXURE VIII tothis report;

ix) Details of short-term provisions as restated as appearing in ANNEXURE IX to thisreport;

x) Details of deferred tax assets (net) as restated as appearing in ANNEXURE X to thisreport;

xi) Details of long-term loans and advances as restated as appearing in ANNEXURE XI tothis report;

xii) Details of inventories as restated as appearing in ANNEXURE XII to this report;

xiii) Details of trade receivables as restated as appearing in ANNEXURE XIII to thisreport;

xiv) Details of cash and cash equivalents as restated as appearing in ANNEXURE XIV tothis report;

xv) Details of short-term loans and advances as restated as appearing in ANNEXURE XV tothis report;

xvi) Details of other current assets as restated as appearing in ANNEXURE XVI to thisreport;

xvii) Details of revenue from operations as restated as appearing in ANNEXURE XVII Itothis report;

xviii) Details of other income as restated as appearing in ANNEXURE XVIII Ito thisreport;

xix) Details of purchase of stock-in-trade as restated as appearing in ANNEXURE XIX Itothis report;

xx) Details of changes in inventories of stock-in-trade as restated as appearing inANNEXURE XX Ito this report;

xxi) Details of employee benefit expenses as restated as appearing in ANNEXURE XXI tothis report;

xxii) Details of finance costs as restated as appearing in ANNEXURE XXII to thisreport;

xxiii) Details of other expenses as restated as appearing in ANNEXURE XXIII to thisreport;

xxiv) Details of bifurcative other income as restated as appearing in ANNEXURE XXIV tothis report;

xxv) Details of contingent liabilities and commitments as restated as appearing inANNEXURE XXV to this report;

xxvi) Details of related party transactions as restated as appearing in ANNEXURE XXVIto this report;

xxvii) Summary of significant accounting ratios as restated as appearing in ANNEXUREXXVII to this report

xxviii) Statement of tax shelters as restated as appearing in ANNEXURE XXVIII to thisreport;

xxix) Capitalisation statement as at March 31 2021 as restated as appearing inANNEXURE XXIX to this report;

10. The report should not in any way be construed as a re-issuance or re-dating of anyof the previous audit reports issued by any other firm of Chartered Accountants nor shouldthis report be construed as a new opinion on any of the financial statements referred totherein.

11. We have no responsibility to update our report for events and circumstancesoccurring after the date of the report.

12. Our report is intended solely for use of the board of directors for inclusion inthe offer document to be filed with SEBI BSE and Registrar of Companies (Gujarat) inconnection with the proposed SME IPO. Our report should not be used referred to ordistributed for any other purpose except with our prior consent in writing. Accordinglywe do not accept or assume any liability or any duty of care for any other purpose or toany other person to whom this report is shown or into whose hands it may come without ourprior consent in writing.

For PIYUSH KOTHARI & ASSOCIATES
Chartered Accountants
FRN -140711W
Sd/-
PIYUSH KOTHARI
Partner
Membership No. - 158407
UDIN - 21158407AAAABJ3091
Place: Ahmedabad
Date: December 13 2021

.